The U.S. FDA has granted de novo clearance for Epiminder Pty. Ltd.’s Minder implantable device for continuously monitoring brain activity in patients with epilepsy.

Rohan Hoare PhD, CEO of Epiminder, said: " By extending the monitoring window of an EEG from days using current technologies ...

School of Integrated Circuits, Shandong University, Jinan 250100, P. R. China Shenzhen Institute of Shandong University, Shenzhen 518057, P. R. China School of Integrated Circuits, Shandong University ...